MEN syndromes
1Department of Internal Medicine, University of Florence and Regional Centre for Hereditary Endocrine Tumors, Unit of Metabolic Bone Diseases, Florence, Italy.
Abstract:
MEN1 and MEN2 are rare inherited cancer syndromes which express a variety of endocrine and nonendocrine tumors. The improved knowledge of molecular and clinical physiopathology of MEN syndromes, together with the availability of genetic testing, have led to earlier detection and intervention, with consequent reduction of mortality and morbidity for MEN-associated tumors. Genetic testing has gained a key role in the detection of asymptomatic patients harbouring mutations responsible for these syndrome, and allows institution of early and tailored intervention with a positive impact on the course of disease.
Insights
Multiple Endocrine Neoplasia (MEN) syndromes are inherited cancers. Genetic testing enables early detection and intervention, significantly reducing mortality and morbidity associated with these rare conditions.
Area of Science:
- Endocrinology
- Oncology
- Genetics
Background:
- Multiple Endocrine Neoplasia (MEN) types 1 and 2 are rare inherited cancer syndromes.
- These syndromes are characterized by a predisposition to various endocrine and nonendocrine tumors.
- Advances in understanding MEN pathophysiology have improved patient outcomes.
Purpose of the Study:
- To highlight the role of genetic testing in the early detection of MEN syndromes.
- To emphasize the impact of early and tailored interventions on disease course.
- To discuss the reduction in mortality and morbidity for MEN-associated tumors.
Main Methods:
- Review of current knowledge on MEN syndromes.
- Analysis of the impact of genetic testing availability.
- Evaluation of early detection and intervention strategies.
Main Results:
- Genetic testing is crucial for identifying asymptomatic carriers of MEN-associated mutations.
- Early detection and intervention lead to reduced mortality and morbidity.
- Tailored interventions positively impact the clinical course of MEN syndromes.
Conclusions:
- Improved understanding and genetic testing have transformed MEN syndrome management.
- Genetic testing plays a pivotal role in proactive healthcare for hereditary cancer syndromes.
- Early diagnosis and intervention are key to improving survival and quality of life for MEN patients.
Related Concept Videos
Sex Linked Disorders
Sex-linked Disorders
Nondisjunction
Nondisjunction
Nondisjunction
Meiosis I

